Stockreport

SAGE says no M&A discussions are taking place; shares ease 4% premarket [Seeking Alpha]

Sage Therapeutics, Inc.  (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations
PDF In a statement , SAGE Therapeutics (NASDAQ: SAGE ) says CEO Jeff Jonas acknowledged industry interest in the MDD data related to SAGE-217 during an interview but [Read more]